| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 78822612 | FILING DATE | 02/24/2006 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | KING, LINDA M |
L.O. ASSIGNED | 116 |
PUB INFORMATION |
|||
| RUN DATE | 07/12/2006 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 07/11/2006 | ||
| LITERAL MARK ELEMENT | VIVELLE-DOT | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | YES | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | VIVELLE-DOT |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Novartis AG |
| ADDRESS | 4002 Basel, |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of hormonal imbalances and deficiencies, pre- and post menopausal symptoms and osteoporosis as well as women's hormonal or reproductive disorders, ailments and conditions |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 03/31/1999 | FIRST USE IN COMMERCE DATE | 03/31/1999 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| PSEUDO MARK | VIVELLE DOT |
| OWNER OF US REG NOS | 2016175 2095515 2520659 |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 07/11/2006 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 007 |
| 07/11/2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 006 |
| 07/11/2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 005 |
| 07/03/2006 | CNRT | F | NON-FINAL ACTION MAILED | 004 |
| 07/03/2006 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
| 06/26/2006 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
| 03/02/2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Maury M. Tepper, III |
| CORRESPONDENCE ADDRESS | MAURY M. TEPPER, III WOMBLE CARLYLE SANDRIDGE & RICE, PLLC PO BOX 831 RALEIGH, NC 27602-0831 |
| DOMESTIC REPRESENTATIVE | Novartis Pharmaceuticals Corporation |